文献速递重症综合管理与镇静镇痛

全球重症监护病房临终实践差异(Ethicus-2):一项前瞻性观察研究

Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study.
PubMed 文献 · Lancet Respir Med · 2021-08-06

限制决策与地区、年龄、急慢性诊断及国家临终立法相关。

要点

  • 限制治疗决策后仍有五分之一患者存活出院(原文:One in five patients with treatment limitations survived hospitalisation)。
  • 与限制治疗相关的因素包括地区、年龄、急性及慢性诊断、国家临终立法。

适用人群与场景

  • 36国199个ICU中2015年9月1日至2016年9月30日6个月期间连续收治的成人ICU患者,且死亡或发生限制生命维持治疗(放弃、撤除或加速死亡进程);脑死亡患者纳入单独预设类别。
  • 患者随访至死亡或自首次限制决策起2个月。

诊断标准与关键阈值

  • 临终实践分类:放弃生命维持治疗、撤除生命维持治疗、加速死亡进程、CPR失败;脑死亡为单独预设类别。
  • 限制生命维持治疗定义为放弃或撤除生命维持治疗及加速死亡进程。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 限制治疗决策后五分之一患者存活出院;限制治疗相关因素为地区、年龄、急慢性诊断及国家临终立法。

证据类型、等级与局限

  • 证据类型:前瞻性多国观察性研究;无资助(Funding: None)。
  • 局限:观察性设计无法推断因果;各区域数据收集实践与立法背景不同可能影响分类比较;原文未报告证据等级。

对床旁实践的改变

  • 限制治疗后仍有五分之一患者存活出院,决策时需向家属说明这一可能结局。

指南或共识出处

  • 原文未提及指南或共识名称;研究发表于Lancet Respir Med。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: End-of-life practices vary among intensive care units (ICUs) worldwide. Differences can result in variable use of disproportionate or non-beneficial life-sustaining interventions across diverse world regions. This study investigated global disparities in end-of-life practices.

METHODS: In this prospective, multinational, observational study, consecutive adult ICU patients who died or had a limitation of life-sustaining treatment (withholding or withdrawing life-sustaining therapy and active shortening of the dying process) during a 6-month period between Sept 1, 2015, and Sept 30, 2016, were recruited from 199 ICUs in 36 countries. The primary outcome was the end-of-life practice as defined by the end-of-life categories: withholding or withdrawing life-sustaining therapy, active shortening of the dying process, or failed cardiopulmonary resuscitation (CPR). Patients with brain death were included in a separate predefined end-of-life category. Data collection included patient characteristics, diagnoses, end-of-life decisions and their timing related to admission and discharge, or death, with comparisons across different regions. Patients were studied until death or 2 months from the first limitation decision.

FINDINGS: Of 87 951 patients admitted to ICU, 12 850 (14·6%) were included in the study population. The number of patients categorised into each of the different end-of-life categories were significantly different for each region (p<0·001). Limitation of life-sustaining treatment occurred in 10 401 patients (11·8% of 87 951 ICU admissions and 80·9% of 12 850 in the study population). The most common limitation was withholding life-sustaining treatment (5661 [44·1%]), followed by withdrawing life-sustaining treatment (4680 [36·4%]). More treatment withdrawing was observed in Northern Europe (1217 [52·8%] of 2305) and Australia/New Zealand (247 [45·7%] of 541) than in Latin America (33 [5·8%] of 571) and Africa (21 [13·0%] of 162). Shortening of the dying process was uncommon across all regions (60 [0·5%]). One in five patients with treatment limitations survived hospitalisation. Death due to failed CPR occurred in 1799 (14%) of the study population, and brain death occurred in 650 (5·1%). Failure of CPR occurred less frequently in Northern Europe (85 [3·7%] of 2305), Australia/New Zealand (23 [4·3%] of 541), and North America (78 [8·5%] of 918) than in Africa (106 [65·4%] of 162), Latin America (160 [28·0%] of 571), and Southern Europe (590 [22·5%] of 2622). Factors associated with treatment limitations were region, age, and diagnoses (acute and chronic), and country end-of-life legislation.

INTERPRETATION: Limitation of life-sustaining therapies is common worldwide with regional variability. Withholding treatment is more common than withdrawing treatment. Variations in type, frequency, and timing of end-of-life decisions were observed. Recognising regional differences and the reasons behind these differences might help improve end-of-life care worldwide.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

参考来源

  1. Avidan A, Sprung CL, Schefold JC, et al. Variations in end-of-life practices in intensive care units worldwide (Ethicus-2): a prospective observational study. Lancet Respir Med. 2021. PMID: 34364537. doi:10.1016/S2213-2600(21)00261-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。